Seres Therapeutics, Inc. (MCRB) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Seres Therapeutics, Inc. (MCRB) Earnings Overview
As of June 22, 2026, Seres Therapeutics, Inc. (MCRB) reported trailing twelve-month net income of -$47M, reflecting +103.4% year-over-year growth. The company earned $-4.89 per diluted share over the past four quarters, with a net profit margin of 721.9%.
Looking at the long-term picture, MCRB's historical earnings data spans multiple years. The company achieved its highest annual net income of $6M in fiscal 2025, representing a new all-time high.
Seres Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$158M net income, -297.1% margin), MIRM (-$799M net income, -4.5% margin), ARWR (-$301M net income, -0.2% margin), MCRB has outperformed on profitability metrics. Compare MCRB vs NKTR →
MCRB Earnings vs Peers
Earnings metrics vs comparable public companies
MCRB Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6M | +4088.2% | -$94M | $0.64 | 721.9% | -11910.1% |
| 2024 | $136,000 | +100.1% | -$121M | $-18.86 | - | - |
| 2023 | -$114M | +54.5% | -$195M | $-17.77 | - | - |
| 2022 | -$250M | -281.5% | -$180M | $-46.29 | - | - |
| 2021 | -$66M | +26.4% | -$64M | $-14.30 | -45.2% | -44.5% |
| 2020 | -$89M | -26.8% | -$88M | $-22.34 | -268.3% | -265.3% |
| 2019 | -$70M | +29.0% | -$72M | $-24.81 | -203.7% | -208.3% |
| 2018 | -$99M | -10.7% | -$100M | $-48.57 | -350.0% | -354.8% |
| 2017 | -$89M | +2.4% | -$91M | $-44.19 | -278.4% | -284.7% |
| 2016 | -$92M | -67.2% | -$93M | $-46.00 | -420.7% | -426.5% |
| 2015 | -$55M | -227.8% | -$55M | $-46.60 | - | - |
| 2014 | -$17M | -173.8% | -$15M | $-9.24 | - | - |
| 2013 | -$6M | -95.2% | -$6M | $-3.58 | - | - |
| 2012 | -$3M | - | -$3M | $-1.75 | - | - |
Download Data
Export MCRB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MCRB — Frequently Asked Questions
Quick answers to the most common questions about buying MCRB stock.
What is MCRB earnings per share (EPS)?
MCRB trailing twelve-month (TTM) diluted EPS is $-4.89, reflecting +103.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Seres Therapeutics, Inc.'s net income?
Seres Therapeutics, Inc. (MCRB) trailing twelve-month net income is $-47M as of 2025. Earnings grew +103.4% year-over-year. Seres Therapeutics, Inc. has been profitable for 2 consecutive years.
Is MCRB profitable?
MCRB is not currently profitable on a TTM basis, reporting a net loss of $-47M. Net margin is +721.9%. Investors should monitor for a return to profitability.
What is MCRB's earnings growth rate?
MCRB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are MCRB's profit margins?
Seres Therapeutics, Inc. net profit margin is +721.9%, operating margin is -11910.1%, and gross margin is -423.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +19.6%.
Is MCRB growing earnings?
Yes, MCRB earnings are accelerating — EPS growth of +103.4% exceeds the 5-year CAGR of N/A. TTM net income reached $-47M. Earnings momentum is strengthening.
What was MCRB's best earnings year?
Seres Therapeutics, Inc.'s highest annual net income on record is $6M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were MCRB's earnings last quarter?
MCRB's most recent reported quarter was Q1 2026. Net income was $-20M with diluted EPS of $-2.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.